About Alpha-2B adrenergic receptor
Alpha-2B adrenergic receptor (ADRA2B) is a protein
from Homo sapiens identified by UniProt accession
P18089, 450 residues long.
MolForge cross-references it against 0 known binders and
380 disease associations.
Target properties
| Protein name | Alpha-2B adrenergic receptor |
| UniProt accession | P18089 |
| Gene | ADRA2B |
| Organism | Homo sapiens |
| Length | 450 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (16)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (380)
Diseases linked to this target (Open Targets).
- Parkinson disease · score 0.64
- pain · score 0.61
- unipolar depression · score 0.60
- attention deficit hyperactivity disorder · score 0.60
- Nasal congestion · score 0.60
- hypotension · score 0.60
- seasonal allergic rhinitis · score 0.60
- hypertension · score 0.60
- delirium · score 0.60
- asthma · score 0.60
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P18089-F1 | alphafold | PREDICTED | 71.55 | — |
Amino-acid sequence (450 residues)
MDHQDPYSVQ ATAAIAAAIT FLILFTIFGN ALVILAVLTS RSLRAPQNLF LVSLAAADIL VATLIIPFSL ANELLGYWYF RRTWCEVYLA LDVLFCTSSI VHLCAISLDR YWAVSRALEY NSKRTPRRIK CIILTVWLIA AVISLPPLIY KGDQGPQPRG RPQCKLNQEA WYILASSIGS FFAPCLIMIL VYLRIYLIAK RSNRRGPRAK GGPGQGESKQ PRPDHGGALA SAKLPALASV ASAREVNGHS KSTGEKEEGE TPEDTGTRAL PPSWAALPNS GQGQKEGVCG ASPEDEAEEE EEEEEEEEEC EPQAVPVSPA SACSPPLQQP QGSRVLATLR GQVLLGRGVG AIGGQWWRRR AQLTREKRFT FVLAVVIGVF VLCWFPFFFS YSLGAICPKH CKVPHGLFQF FFWIGYCNSS LNPVIYTIFN QDFRRAFRRI LCRPWTQTAW
Explore Alpha-2B adrenergic receptor with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets